New shot could zap skin cancer without surgery
Disease control
Recruiting now
This early-phase trial tests an injected drug called FLD-103 for nodular basal cell carcinoma, a common skin cancer. About 48 adults will receive either one or several injections directly into their tumor. The main goal is to check safety and find the right dose, while also seein…
Phase: PHASE1 • Sponsor: Feldan Therapeutics • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC